Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 54: 475-481, 2008. First published January 17, 2008; 10.1373/clinchem.2007.095521
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2007.095521v1
54/3/475    most recent
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Lauretani, F.
Right arrow Articles by Ferrucci, L.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lauretani, F.
Right arrow Articles by Ferrucci, L.
(Clinical Chemistry. 2008;54:475-481.)
© 2008 American Association for Clinical Chemistry, Inc.

Lipids, Lipoproteins, and Cardiovascular Risk Factors

Plasma Polyunsaturated Fatty Acids and the Decline of Renal Function

Fulvio Lauretani1,4, Richard D. Semba2, Stefania Bandinelli3, Edgar R. Miller, III2,4, Carmelinda Ruggiero4,5, Antonio Cherubini5, Jack M. Guralnik6 and Luigi Ferrucci4,a

1 Tuscany Regional Agency, Florence, Italy;2 Johns Hopkins School of Medicine, Baltimore, MD;3 Geriatric Unit, Azienda Sanitaria Firenze, Florence, Italy;4 Longitudinal Studies Section, Clinical Research Branch, National Institute on Aging, Baltimore, MD;5 Institute of Gerontology and Geriatrics, Perugia University Medical School, Perugia, Italy;6 Laboratory of Epidemiology, Demography and Biometry, National Institute on Aging, Bethesda, MD.

aAddress correspondence to this author at: Luigi Ferrucci, National Institute on Aging, Longitudinal Studies Section, ASTRA Unit, Harbor Hospital 5th Floor, 3001 S. Hanover St., Baltimore, MD 21225. Fax 410-350-7304; e-mail ferruccilu{at}grc.nia.nih.gov.

Background: Recent studies suggest an association between polyunsaturated fatty acids (PUFAs) and the development of chronic kidney disease. The aim of this study was to examine the relationship between PUFAs and renal function in older adults.

Methods: We performed a cross-sectional and prospective analysis of 931 adults, ≥65 years old, enrolled in the InCHIANTI study, a population-based cohort in Tuscany, Italy. Plasma PUFAs were measured at enrollment, and creatinine clearance was estimated by the Cockcroft-Gault equation at baseline and after 3-year follow-up.

Results: At enrollment, participants with higher creatinine clearance had higher concentrations of HDL cholesterol, total plasma PUFAs, plasma n-3 fatty acid (FA), and plasma n-6 FA and lower triglycerides. From enrollment to the 3-year follow-up visit, creatinine clearance declined by 7.8 (12.2) mL/min (P <0.0001). Baseline total plasma PUFAs, n-3 FA, n-6 FA, and linoleic, linolenic, and arachidonic acids were strong independent predictors of less steep decline in creatinine clearance from baseline to follow-up (P <0.0001, after adjusting for baseline creatinine clearance). After adjusting for baseline creatinine, baseline total plasma PUFAs, n-3 FA, and linoleic, linolenic, and arachidonic acids were negatively associated with creatinine at 3-year follow-up. Participants with higher plasma PUFAs at enrollment had a lower risk of developing renal insufficiency, defined by a creatinine clearance <60 mL/min, during 3-year follow-up.

Conclusion: High PUFA concentrations, both n-3 FA and n-6 FA, may attenuate the age-associated decline in renal function among older community-dwelling women and men.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Association for Clinical Chemistry.